Government updates Drugs Rules to modernise regulation of AYUSH medicines

India's Ministry of AYUSH has notified amendment to drugs rules, introducing perpetual manufacturing and loan licences, a Standard Product Code for AYUSH medicines, digital labelling through QR codes and barcodes, risk- based inspections, revised GMP requirements, and a framework for provisional shelf life based on accelerated stability studies. The AYUSH drug manufacturers to benefit from revised licensing and compliance framework.

Join our 1500+ subscribers to get our daily Health Laws and Policy Updates.